Volcanic NeuroBalance ASD® - Vitamina D, Coenzima Q10, Palmitoiletanolamida (PEA), Proantocianidinas de Semente de Uva e Trans-resveratrol - 60g - Sem sabor

Volcanic NeuroBalance ASD® – Inovação para o Suporte ao TEA

O Volcanic NeuroBalance ASD® é um suplemento revolucionário, desenvolvido com base na ciência para oferecer suporte natural e eficaz para pessoas  com Transtorno do Espectro Autista (TEA). Com a crescente prevalência do TEA e opções farmacêuticas limitadas, essa fórmula inovadora chega como uma alternativa segura e cientificamente respaldada com suplementos que podem ajudar a melhorar sintomas associados ao desenvolvimento cognitivo, comunicação e comportamento.

Ciência e Tecnologia para uma Vida Melhor

Cada ingrediente do Volcanic NeuroBalance ASD® foi criteriosamente selecionado com base em evidências científicas que demonstram benefícios diretos para indivíduos com TEA:

• - PEA – Palmitoiletanolamida - 300mg: auxilia na redução da irritabilidade e da agressividade, ajudando no equilíbrio emocional.
• - Vitamina D - 25mcg: Essencial para o desenvolvimento cognitivo e elevação da serotonina, influencia positivamente no humor e no comportamento social.
• - Coenzima Q10 - 60mg: Contribui para clareza mental, cognição e interação social, auxilia no aprimoramento da comunicação verbal.
• - Trans-Resveratrol - 100mg:  Atua como anti-inflamatório natural, contribui para a redução da hiperatividade e a melhora do comportamento.
• - Proantocianidinas de sementes de uva - 114mg: Poderoso antioxidante com efeito imunomodulador, que contribui para o desenvolvimento da fala e a melhora na comunicação.
• *quantidades por dose

Público:

• - Indivíduos com TEA que necessitam de suporte nutricional para promover equilíbrio emocional, neuroproteção e melhora na interação social.
• - Indivíduos com hipersensibilidade sensorial e desafios na regulação emocional, que podem se beneficiar de ingredientes que auxiliam na estabilidade do humor.
• - Pessoas com dificuldades de comunicação verbal que buscam suporte nutricional para otimizar a função neurológica e promover o desenvolvimento da fala.

Recomendações de Uso do Volcanic NeuroBalance ASD®:

• - Adicionar 2g (1/2 (meia) medida dosadora) sobre a comida ou bebida e misturar, ou conforme orientação do médico ou  nutricionista.
• - Consumir 1 vez ao dia ou conforme orientação do seu médico ou nutricionista.

Pesquisa científica que atesta os resultados do NeuroBalance consiste no uso concomitante do NeuroBalance ASD com o NeuroBalance Melatonin, disponibilizado para compra com desconto no Combo NeuroBalance.

👉 Para acesso ao artigo científico publicado com o Combo  NeuroBalance: https://www.sciencedirect.com/science/article/pii/S0166432825002396

👉 Para acesso ao dossiê técnico dos ativos do Combo NeuroBalance: https://docsend.com/v/g6x4v/neurobalance

Referências Bibliográficas:

• - A Randomised Placebo-Controlled Study of Purified Anthocyanins on Cognition in Individuals at Increased Risk for Dementia. Dag Aarsland, Khadija Khalifa, Anne K Bergland, Hogne Soennesyn, Ketil Oppedal, Lise B A Holteng, Ragnhild Oesterhus, Arne Nakling, Jonas A Jarholm,  Chiara de Lucia, Tormod Fladby, Helen Brooker, Ingvild Dalen, Clive Ballard.
• - A Randomized, Crossover Study of the Acute Cognitive and Cerebral Blood Flow Effects of Phenolic, Nitrate and Botanical Beverages in Young, Healthy Humans. Philippa A Jackson, Emma L Wightman, Rachel Veasey, Joanne Forster, Julie Khan, Caroline Saunders, Siobhan Mitchell, Crystal F Haskell-Ramsay, David O Kennedy
• - Aarsland D et al. A Randomised Placebo-Controlled Study of Purified Anthocyanins on Cognition in Individuals at Increased Risk for Dementia. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 31(2), 141–151.
• - Antonucci et al. Beneficial effects of palmitoylethanolamide on expressive language, cognition, and behaviors in autism: a report of two cases. Case reports in psychiatry, v. 2015, n. 1, p. 325061, 2015.
• - Attenuation of Autism-like Behaviors by an Anthocyanin-Rich Extract from Portuguese Blueberries via Microbiota–Gut–Brain Axis Modulation Mouse Model. Diana Serra, Joana F. Henriques, Fábio J. Sousa, Mariana Laranjo, Rosa Resende, Marisa Ferreira-Marques , Victor de Freitas, Gabriela Silva, João Peça, Teresa C. P. Dinis  e Leonor M. Almeida.
• - Bagheri S, et al. Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article. Front Neurosci. 2023 Jun 23;17:1188839.
• - Beneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: A Report of Two Cases. Nicola Antonucci, Alessandra Cirillo, Dario Siniscalco
• - Cirilli I, et al. Role of Coenzyme Q10 in Health and Disease: An Update on the Last 10 Years (2010-2020). Antioxidants (Basel). 2021 Aug 23;10(8):1325.
• - Clayton, P.; Hill, M.; Subah, S.; Venkatesh, R. Palmitoiletanolamida: Um composto natural para gestão da saúde. Int. J. Mol. Sci. 2021 , 22;
• - Clinical improvement following vitamin D3 supplementation in Autism Spectrum Disorder. Junyan Feng, Ling Shan, Lin Du, Bing Wang, Honghua Li, Wei Wang, Tiantian Wang, Hanyu Dong, Xiaojing Yue, Zhida Xu, Wouter G. Staal, Feiyong Jia
• - Coenzyme Q10 supplementation reduces oxidative stress and decreases antioxidant enzyme activity in children with autism spectrum disorders. Elham Mousavinejad, Mohammad Ali Ghaffari, Forough Riahi, Maryam Hajmohammadi, Zeinab Tiznobeyk e Masoumeh Mousavinejad 
• - Ebrahimi A, et al. Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases. Biochem Res Int. 2023 Nov 1;2023:5510874.
• - Eleanor et al. Wild blueberry (poly) phenols can improve vascular function and cognitive performance in healthy older individuals: a double-blind randomized controlled trial. The American journal of clinical nutrition, v. 117, n. 6, p. 1306-1319, 2023.
• - Feng J, et al. Clinical improvement following vitamin D3 supplementation in Autism Spectrum Disorder. Nutr Neurosci. 2017 Jun;20(5):284-290.
• - Gvozdjáková A et al. Ubiquinol improves symptoms in children with autism. Oxid Med Cell Longev. 2014;2014:798957.
• - Hendouei F, et al. Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial. J Clin Pharm Ther. 2020 Apr;45(2):324-334.
• - Herrera MI, et al. Palmitoylethanolamide attenuates neurodevelopmental delay and early hippocampal damage following perinatal asphyxia in rats. Front Behav Neurosci. 2022 Aug 25;16:953157. doi: 10.3389/fnbeh.2022.953157. Erratum in: Front Behav Neurosci. 2022 Dec 19;16:1115398.
• - Jackson PA, et al. A Randomized, Crossover Study of the Acute Cognitive and Cerebral Blood Flow Effects of Phenolic, Nitrate and Botanical Beverages in Young, Healthy Humans. Nutrients. 2020 Jul 28;12(8):2254
• - Khalaj M, Saghazadeh A, Shirazi E, et al. Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial. J Psychiatr Res. 2018 Aug;103:104-111.
• - Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder. Athanasios Maras, Carmen M. Schroder, Beth A. Malow, Robert L. Findling, John Breddy, Tali Nir, Shiri Shahmoon, Nava Zisapel, and Paul Gringras
• - Long-term melatonin treatment for the sleep problems and aberrant behaviors of children with neurodevelopmental disorders. Kotaro Yuge, Shinichiro Nagamitsu, Yuko Ishikawa, Izumi Hamada, Hiroyuki Takahashi, Hideyuki Sugioka, Osamu Yotsuya, Kazuo Mishima, Masaharu Hayashi & Yushiro Yamashita
• - Maras A, Schroder CM, Malow BA, et al. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder. J Child Adolesc Psychopharmacol. 2018 Dec;28(10):699-710.
• - Marchezan J, Deckmann I, da Fonseca GC, Margis R, Riesgo R, Gottfried C. Resveratrol Treatment of Autism Spectrum Disorder-A Pilot Study. Clin Neuropharmacol. 2022 Sep-Oct 01;45(5):122-127.
• - Mei  Xiong et al. Efficacy of Melatonin for Insomnia in Children with Autism Spectrum Disorder: A Meta-analysis. Neuropediatrics. 2023 Jun; 54(3):167-173.  2.  Souders M C et al. Sleep in children with autism spectrum disorder. Curr Psychiatry Rep. 2017;19(06):34.
• - Melatonin Versus Placebo in Children with Autism Spectrum Conditions and Severe Sleep Problems Not Amenable to Behaviour Management Strategies: A Randomised Controlled Crossover Trial
• - Menegas S, et al. Potential mechanisms of action of resveratrol in prevention and therapy for mental disorders. J Nutr Biochem. 2023 Nov;121:109435.
• - Moore M. et al. Assessment of sleep in children with autism spectrum disorder. Children (Basel). 2017 Aug 8;4(8):72.
• - Mousavinejad E, et al. Coenzyme Q10 supplementation reduces oxidative stress and decreases antioxidant enzyme activity in children with autism spectrum disorders. Psychiatry Res. 2018 Jul;265:62-69.
• - Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial. Mona Khalaja, Amene Saghazadehb, Elham Shirazia, Mohammad-Reza Shalbafana, Kaveh Alavia, Mitera Hakim Shooshtaria, Fatemeh Yousefi Laksaria, Maryamalsadat Hosseinia, Mohammad-Reza Mohammadib e Shahin Akhondzadeh (2018)
• - Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial. Khalaj, M., Saghazadeh, A., Shirazi, E., Shaibafan, M. R., Alavi, K., Shooshari, M. H.,  & Akhondzadeh, S.
• - Panchal, S.K.; Brown, L. Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System. Molecules 2023, 28, 80.
• - Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver’s Quality of Life. Carmen M. Schroder, Beth A. Malow, Athanasios Maras, Raun D. Melmed, Robert L. Findling, John Breddy, Tali Nir, Shiri Shahmoon, Nava Zisapel & Paul Gringras
• - Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial. Fatemeh Hendouei, Hossein Sanjari Moghaddam, Mohammad Reza Mohammadi, Negin Taslimi, Farzin Rezaei, Shahin Akhondzadeh
• - Resveratrol Treatment of Autism Spectrum Disorder – A Pilot Study. Marchezan, Josemar PhD; Deckmann, Iohanna PhD; da Fonseca, Guilherme Cordenonsi PhD; Margis, Rogerio PhD; Riesgo, Rudimar PhD; Gottfried, Carmem PhD
• - Schroder CM, Malow BA, Maras A, et al. Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life. J Autism Dev Disord. 2019 Aug;49(8):3218-3230.
• - Serra D, Henriques JF, Sousa FJ, Laranjo M,, et al. Attenuation of Autism-like Behaviors by an Anthocyanin-Rich Extract from Portuguese Blueberries via Microbiota–Gut–Brain Axis Modulation in a Valproic Acid Mouse Model. International Journal of Molecular Sciences. 2022; 23(16):9259.
• - Tordjman S. et al. Melatonin: Pharmacology, Functions and Therapeutic Benefits. Curr Neuropharmacol. 2017 Apr;15(3):434-443.  2. Zhou-yue Wu et al. Autism spectrum disorder (ASD): Disturbance of the melatonin system and its implications. Biomed Pharmacother. 2020 Oct; 130:110496. 
• - Wild blueberry (poly)phenols can improve vascular function and cognitive performance in healthy older individuals: a double-blind randomized controlled trial. Eleanor Wood, Sabine Hein, Robin Mesnage, Filipe Fernandes, Nimaya Abhayaratne, Yifan Xu, Zicheng Zhang, Lynne Bell, Claire Williams, Ana Rodriguez-Mateos.
• - Wimalawansa SJ. Vitamin D Deficiency: Effects on Oxidative Stress, Epigenetics, Gene Regulation, and Aging. Biology (Basel). 2019 May 11;8(2):30.
• - Wright B, Sims D, Smart S, et al. Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial. J Autism Dev Disord. 2011 Feb;41(2):175-84.
• - Yuge K, Nagamitsu S, Ishikawa Y, et al. Long-term melatonin treatment for the sleep problems and aberrant behaviors of children with neurodevelopmental disorders. BMC Psychiatry. 2020 Sep 10;20(1):445.

Conforme regulamentação da ANVISA, suplementos alimentares são recomendados para indivíduos a partir de 19 anos. O uso por menores de 19 anos somente deve ocorrer sob indicação médica. Este produto não é um medicamento, não exceder a recomendação diária de consumo indicada na embalagem.